Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AmBisome' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 198 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Knoppert, DC; Salama, HEM; Lee, DSC
      Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex

      ANNALS OF PHARMACOTHERAPY
    2. Bishara, J; Weinberger, M; Lin, AY; Pitlik, S
      Amphotericin B - Not so terrible

      ANNALS OF PHARMACOTHERAPY
    3. Ellis, M; Shamoon, A; Gorka, W; Zwaan, F; al-Ramadi, B
      Severe hepatic injury associated with lipid formulations of amphotericin B

      CLINICAL INFECTIOUS DISEASES
    4. Fleming, RV; Kantarjian, HM; Husni, R; Rolston, K; Lim, J; Raad, I; Pierce, S; Cortes, J; Estey, E
      Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia

      LEUKEMIA & LYMPHOMA
    5. Sundar, S; Agrawal, G; Rai, M; Makharia, MK; Murray, HW
      Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial

      BRITISH MEDICAL JOURNAL
    6. Thakur, CP
      A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    7. Datry, A; Thellier, M; Traore, B; Cisse, OA; Danis, M
      Antifungal drugs in the treatment of systemic candidiosis: susceptibility to antifungal drugs, point on drug resistance, pharmacological data.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    8. Fielding, RM
      Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: Implications for the characterization of liposomal formulations

      PHARMACEUTICAL RESEARCH
    9. Eldem, T; Arican-Cellat, N; Agabeyoglu, I; Akova, M; Kansu, E
      Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    10. Ruijgrok, EJ; Vulto, AG; Van Etten, EWM
      Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats

      Journal of antimicrobial chemotherapy
    11. Garey, KW; Pendland, SL; Huynh, VT; Bunch, TH; Jensen, GM; Pursell, KJ
      Cunninghamella bertholletiae infection in a bone marrow transplant patient: Amphotericin lung penetration, MIC determinations, and review of the literature

      PHARMACOTHERAPY
    12. Podzamczer, D; Mallolas, J; Pena, JM; Pulido, F; Aguirrebengoa, K; Barros, C; Blazquez, R; Costa, JR; Dronda, F; Ena, J; Guerrero, A; Gutierrez, F; Juega, J; Labarga, P; Locutura, J; Aldeguer, JL; Moreno, S; Noguerado, A; Ocana, I; Padilla, B; Perez-Cecilia, E; Elias, MJP; Portilla, J; Rivero, A; Roca, V
      Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    13. Lee, JW; Petersen, ME; Lin, P; Dressler, D; Bekersky, I
      Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method

      THERAPEUTIC DRUG MONITORING
    14. Townsend, RW; Zutshi, A; Bekersky, I
      Biodistribution of 4-[C-14]cholesterol-ambisome following a single intravenous administration to rats

      DRUG METABOLISM AND DISPOSITION
    15. Zijlstra, EE; El-Hassan, AM
      Leishmaniasis in Sudan 3. Visceral leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    16. Dose, B; Kohring, J; Becker, K; Ritter, J; Bramswig, JH; Harms, E
      Visceral leishmaniasis - not only a disease of tropical regions

      MONATSSCHRIFT KINDERHEILKUNDE
    17. Lebrato, JC; Garcia, ET; Escobar, T; Quero, JH
      Treatment of visceral leismaniasis in HIV patients with a new regimen of liposomal amphotericin

      MEDICINA CLINICA
    18. Rodriguez-Wilhelmi, P; Panizo, C; Ruza, E; Rocha, E
      Treatment of visceral leishmaniasis with liposomal amphotericin B in threeimmunocompromised patients

      MEDICINA CLINICA
    19. Singhal, S; Ellis, RW; Jones, SG; Miller, SJ; Fisher, NC; Hastings, JGM; Mutimer, DJ
      Targeted prophylaxis with amphotericin B lipid complex in liver transplantation

      LIVER TRANSPLANTATION
    20. Jessup, C; Reyes, G; Fothergill, A; McCarthy, D; Rinaldi, M; Messer, S; Pfaller, M; Ghannoum, M
      A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study

      JOURNAL OF CHEMOTHERAPY
    21. Larson, JL; Wallace, TL; Tyl, RW; Marr, MC; Myers, CB; Cossum, PA
      The reproductive and developmental toxicity of the antifungal drug Nyotran((R)) (liposomal nystatin) in rats and rabbits

      TOXICOLOGICAL SCIENCES
    22. Sandler, ES; Mustafa, MM; Tkaczewski, I; Graham, ML; Morrison, VA; Green, M; Trigg, M; Abboud, M; Aquino, VM; Gurwith, M; Pietrelli, L
      Use of amphotericin B colloidal dispersion in children

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    23. Maltezou, HC; Siafas, C; Mavrikou, M; Spyridis, P; Stavrinadis, C; Karpathios, T; Kafetzis, DA
      Visceral leishmaniasis during childhood in southern Greece

      CLINICAL INFECTIOUS DISEASES
    24. Saag, MS; Graybill, RJ; Larsen, RA; Pappas, PG; Perfect, JR; Powderly, WG; Sobel, JD; Dismukes, WE
      Practice guidelines for the management of cryptococcal disease

      CLINICAL INFECTIOUS DISEASES
    25. Souza, LC; Saldiva, PHN; Campa, A
      Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    26. Harrington, KJ; Lewanski, CR; Stewart, JSW
      Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development

      CLINICAL ONCOLOGY
    27. Yardley, V; Croft, SL
      A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    28. Zarif, L; Graybill, JR; Perlin, D; Mannino, RJ
      Cochleates: New lipid-based drug delivery system

      JOURNAL OF LIPOSOME RESEARCH
    29. Marcinkowski, M; Bauer, K; Stoltenburg-Didinger, G; Vogel, M; Versmold, H
      Fatal aspergillosis with brain abscesses ln a neonate with digeorge syndrome

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    30. Vyas, SP; Katare, YK; Mishra, V; Sihorkar, V
      Ligand directed macrophage targeting of amphotericin B loaded liposomes

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    31. Stocker, M; Caduff, JH; Spalinger, J; Berger, TM
      Successful treatment of bilateral renal fungal balls with liposomal amphotericin B and fluconazole in an extremely low birth weight infant

      EUROPEAN JOURNAL OF PEDIATRICS
    32. Singh, N
      Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management

      Journal of antimicrobial chemotherapy
    33. Wolff, SN; Fay, J; Stevens, D; Herzig, RH; Pohlman, B; Bolwell, B; Lynch, J; Ericson, S; Freytes, CO; LeMaistre, F; Collins, R; Pineiro, L; Greer, J; Stein, R; Goodman, SA; Dummer, S
      Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

      BONE MARROW TRANSPLANTATION
    34. Espuelas, S; Legrand, P; Loiseau, PM; Bories, C; Barratt, C; Irache, JM
      In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. van Etten, EWM; van Vianen, W; Roovers, P; Frederik, P
      Mild heating of amphotericin B-desoxycholate: Effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    36. Echevarria, I; Barturen, C; Renedo, MJ; Troconiz, IF; Dios-Vieitez, MC
      Comparative pharmacokinetics, tissue distributions, and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B-deoxycholate in rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Machard, S; Theodoro, F; Benech, H; Grognet, JM; Ezan, E
      A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    38. Groll, AH; Mickiene, D; Piscitelli, SC; Walsh, TJ
      Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    39. Inselmann, G; Volkmann, A; Heidemann, HT
      Comparison of the effects of liposomal amphotericin B and conventional amphotericin B on propafenone metabolism and hepatic cytochrome P-450 in rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    40. Gaeta, GB; Maisto, A; Di Caprio, D; Scalone, A; Pasquale, G; Felaco, FM; Galante, D; Gradoni, L
      Efficacy of amphotericin B colloidal dispersion in the treatment of mediterranean visceral leishmaniasis in immunocompetent adult patients

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    41. Sundar, S; Gupta, LB; Rastogi, V; Agrawal, G; Murray, HW
      Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    42. Heussel, CP; Kauczor, HU; Heussel, G; Derigs, HG; Thelen, M
      Looking for the cause in neutropenic fever. Imaging diagnostics

      RADIOLOGE
    43. Groll, AH; Giri, N; Petraitis, V; Petraitiene, R; Candelario, M; Bacher, JS; Piscitelli, SC; Walsh, TJ
      Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system

      JOURNAL OF INFECTIOUS DISEASES
    44. Reyes, E; Cardona, J; Prieto, A; Bernstein, ED; Rodriguez-Zapata, M; Pontes, MJ; Alvarez-Mon, M
      Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells

      JOURNAL OF INFECTIOUS DISEASES
    45. Eldem, T; Arican-Cellat, N
      High-performance liquid chromatographic determination of amphotericin B ina liposomal pharmaceutical product and validation of the assay

      JOURNAL OF CHROMATOGRAPHIC SCIENCE
    46. Barwicz, J; Gruda, I; Tancrede, P
      A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins

      FEBS LETTERS
    47. Harrington, KJ; Rowlinson-Busza, G; Syrigos, KN; Uster, PS; Abra, RM; Stewart, JSW
      Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies

      BRITISH JOURNAL OF CANCER
    48. Plotnick, AN
      Lipid-based formulations of amphotericin B

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    49. Rabkin, JM; Oroloff, SL; Corless, CL; Benner, KG; Flora, KD; Rosen, HR; Olyaei, AJ
      Association of fungal infection and increased mortality in liver transplant recipients

      AMERICAN JOURNAL OF SURGERY
    50. Bekersky, I; Fielding, RM; Buell, D; Lawrence, I
      Lipid-based amphotericin B formulations: from animals to man

      PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY
    51. Chisholm, J; Devine, T; Mycroft, J; Pinkerton, CR
      Liposomal amphotericin B (AmBisome) in children with febrile neutropenia and renal dysfunction

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    52. Rex, JH; Walsh, TJ
      Editorial response: Estimating the true cost of amphotericin B

      CLINICAL INFECTIOUS DISEASES
    53. Karp, CL; Neva, FA
      Tropical infectious diseases in human immunodeficiency virus-infected patients

      CLINICAL INFECTIOUS DISEASES
    54. Cesaro, S; Calore, E; Messina, C; Zanesco, L
      Allergic reaction to the liposomal component of liposomal amphotericin B

      SUPPORTIVE CARE IN CANCER
    55. Inselmann, G; Schimanski, A; Jahns, R; Heidemann, HT
      Liposomal amphotericin B (AmBisome((R))) application and hepatic microsomal enzyme function in the rat

      MYCOSES
    56. Lorf, T; Braun, F; Ruchel, R; Muller, A; Sattler, B; Ringe, B
      Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome (R)) after liver transplantation

      MYCOSES
    57. Moribe, K; Maruyama, K; Iwatsuru, M
      Molecular localization and state of amphotericin B in PEG liposomes

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    58. Muller, FMC; Groll, AH; Walsh, TJ
      Current approaches to diagnosis and treatment of fungal infections in children infected with human immune deficiency virus

      EUROPEAN JOURNAL OF PEDIATRICS
    59. Laguna, F; Lopez-Velez, R; Pulido, F; Salas, A; Torre-Cisneros, J; Torres, E; Medrano, FJ; Sanz, J; Pico, G; Gomez-Rodrigo, J; Pasquau, J; Alvar, J
      Treatment of visceral leishmaniasis in HIV-infected patients: a randomizedtrial comparing meglumine antimoniate with amphotericin B

      AIDS
    60. Robinson, RF; Nahata, MC
      A comparative review of conventional and lipid formulations of amphotericin B

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    61. Leleu, X; Sendid, B; Fruit, J; Sarre, H; Wattel, E; Rose, C; Bauters, F; Facon, T; Jouet, JP
      Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    62. Kelsey, SM; Goldman, JM; McCann, S; Newland, AC; Scarffe, JH; Oppenheim, BA; Mufti, GJ
      Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study

      BONE MARROW TRANSPLANTATION
    63. Davidson, RN
      Visceral leishmaniasis in clinical practice

      JOURNAL OF INFECTION
    64. Hay, RJ
      Lipid amphotericin B combinations; "la creme de la creme'?

      JOURNAL OF INFECTION
    65. Torres-Santos, EC; Rodrigues, JM; Moreira, DL; Kaplan, MAC; Rossi-Bergmann, B
      Improvement of in vitro and in vivo antileishmanial activities of 2',6 '-dihydroxy-4 '-methoxychalcone by entrapment in poly(D,L-lactide) nanoparticles

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    66. Petit, C; Yardley, V; Gaboriau, F; Bolard, J; Croft, SL
      Activity of a heat-induced reformulation of amphotericin B deoxycholate (Fungizone) against Leishmania donovani

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    67. Walsh, TJ; Finberg, RW; Arndt, C; Hiemenz, J; Schwartz, C; Bodensteiner, D; Pappas, P; Seibel, N; Greenberg, RN; Dummer, S; Schuster, M; Holcenberg, JS
      Liposomal amphotericin B for empirical therapy in patients with persistentfever and neutropenia

      NEW ENGLAND JOURNAL OF MEDICINE
    68. Harindran, J; Chakraborty, KK; Naik, SR
      Preparation, relative toxicity and therapeutic efficacy in mice and rats of liposomal HA-1-92, a new oxohexaene polyene macrolide antibiotic

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    69. Gurwith, M
      Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Aspergillus spp

      CHEMOTHERAPY
    70. Clark, A; Franklin, IM
      Lipid preparations of amphotericin for the treatment of fungal infections - Reponse

      BRITISH JOURNAL OF HAEMATOLOGY
    71. Yardley, V; Croft, SL
      In vitro and in vivo activity of amphotericin B-lipid formulations againstexperimental Trypanosoma cruzi infections

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    72. Dietze, R; Fowler, VG; Steiner, TS; Pecanha, PM; Corey, GR
      Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    73. Burbach, G; May, J; Harms, G; Bienzle, U
      Leishmaniasis

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    74. SPERRY PJ; CUA DJ; WETZEL SA; ADLERMOORE JP
      ANTIMICROBIAL ACTIVITY OF AMBISOME AND NON-LIPOSOMAL AMPHOTERICIN-B FOLLOWING UPTAKE OF CANDIDA-GLABRATA BY MURINE EPIDERMAL LANGERHANS CELLS

      MEDICAL MYCOLOGY
    75. SINGH RM; PERDUE BE
      AMPHOTERICIN-B - A CLASS REVIEW

      Formulary
    76. RUDICH SM; KINKHABWALA MM; MURRAY NGB; SEE DM; BUSUTTIL RW; IMAGAWA DK
      SUCCESSFUL TREATMENT OF MYCOTIC HEPATIC-ARTERY PSEUDOANEURYSMS WITH ARTERIAL RECONSTRUCTION AND LIPOSOMAL AMPHOTERICIN-B

      Liver transplantation and surgery
    77. WORTMANN GW; FRASER SL; ARONSON NE; DAVIS C; MILLER RS; JACKSON JD; OSTER CN
      FAILURE OF AMPHOTERICIN-B LIPID COMPLEX IN THE TREATMENT OF CUTANEOUSLEISHMANIASIS

      Clinical infectious diseases
    78. Ellis, M; Spence, D; de Pauw, B; Meunier, F; Marinus, A; Collette, L; Sylvester, R; Meis, J; Boogaerts, M; Selleslag, D; Kremery, V; von Sinner, W; MacDonald, P; Doyen, C; Vandercam, B
      An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis

      CLINICAL INFECTIOUS DISEASES
    79. Berman, J
      Chemotherapy of leishmaniasis: recent advances in the treatment of visceral disease

      CURRENT OPINION IN INFECTIOUS DISEASES
    80. KORFEL A; MENSSEN HD; SCHWARTZ S; THIEL E
      CRYPTOCOCCOSIS IN HODGKINS-DISEASE - DESCRIPTION OF 2 CASES AND REVIEW OF THE LITERATURE

      Annals of hematology
    81. POLAK A
      EXPERIMENTAL-MODELS IN ANTIFUNGAL CHEMOTHERAPY

      Mycoses
    82. SALLOVITZ JM; MENGHINI MIZ; LANUSSE CE
      IMPACT OF LIPOSOMES AS DELIVERY SYSTEMS IN VETERINARY-MEDICINE

      Veterinary research
    83. Hiemenz, JW; Walsh, TJ
      Lipid formulations of amphotericin B

      JOURNAL OF LIPOSOME RESEARCH
    84. SCARCELLA A; PASQUARIELLO MB; GIUGLIANO B; VENDEMMIA M; DELUCIA A
      LIPOSOMAL AMPHOTERICIN-B TREATMENT FOR NEONATAL FUNGAL-INFECTIONS

      The Pediatric infectious disease journal
    85. Al Arishi, H; Frayha, HH; Kalloghlian, A; Al Alaiyan, S
      Liposomal amphotericin B in neonates with invasive candidiasis

      AMERICAN JOURNAL OF PERINATOLOGY
    86. BAKKERWOUDENBERG IAJM; TENKATE MT; STORM G; VANETTEN EWM
      ADMINISTRATION OF LIPOSOMAL AGENTS AND THE PHAGOCYTIC FUNCTION OF THEMONONUCLEAR PHAGOCYTE SYSTEM

      International journal of pharmaceutics
    87. Petit, C; Cheron, M; Joly, V; Rodrigues, JM; Bolard, J; Gaboriau, F
      In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating

      Journal of antimicrobial chemotherapy
    88. BEAULAC C; SACHETELLI S; LAGACE J
      IN-VITRO BACTERICIDAL EFFICACY OF SUB-MIC CONCENTRATIONS OF LIPOSOME-ENCAPSULATED ANTIBIOTIC AGAINST GRAM-NEGATIVE AND GRAM-POSITIVE BACTERIA

      Journal of antimicrobial chemotherapy
    89. GROLL AH; MULLER FMC; PISCITELLI SC; WALSH TJ
      LIPID FORMULATIONS OF AMPHOTERICIN-B - CLINICAL PERSPECTIVES FOR THE MANAGEMENT OF INVASIVE FUNGAL-INFECTIONS IN CHILDREN WITH CANCER

      Klinische Padiatrie
    90. JOHNSON MD; DREW RH; PERFECT JR
      CHEST DISCOMFORT ASSOCIATED WITH LIPOSOMAL AMPHOTERICIN-B - REPORT OF3 CASES AND REVIEW OF THE LITERATURE

      Pharmacotherapy
    91. GULATI M; BAJAD S; SINGH S; FERDOUS AJ; SINGH M
      DEVELOPMENT OF LIPOSOMAL AMPHOTERICIN-B FORMULATION

      Journal of microencapsulation
    92. DURAND R; PAUL M; PRATLONG F; RIVOLLET D; DUBREUILLEMAIRE ML; HOUIN R; ASTIER A; DENIAU M
      LEISHMANIA-INFANTUM - LACK OF PARASITE RESISTANCE TO AMPHOTERICIN-B IN A CLINICALLY RESISTANT VISCERAL LEISHMANIASIS

      Antimicrobial agents and chemotherapy
    93. VANETTEN EWM; TENKATE MT; SNIJDERS SV; BAKKERWOUDENBERG IAJM
      ADMINISTRATION OF LIPOSOMAL AGENTS AND BLOOD CLEARANCE CAPACITY OF THE MONONUCLEAR PHAGOCYTE SYSTEM

      Antimicrobial agents and chemotherapy
    94. LEFICHOUX Y; ROUSSEAU D; FERRUA B; RUETTE S; LELIEVRE A; GROUSSON D; KUBAR J
      SHORT-TERM AND LONG-TERM EFFICACY OF HEXADECYLPHOSPHOCHOLINE AGAINST ESTABLISHED LEISHMANIA-INFANTUM INFECTION IN BALB C MICE/

      Antimicrobial agents and chemotherapy
    95. BOSWELL GW; BEKERSKY I; BUELL D; HILES R; WALSH TJ
      TOXICOLOGICAL PROFILE AND PHARMACOKINETICS OF A UNILAMELLAR LIPOSOMALVESICLE FORMULATION OF AMPHOTERICIN-B IN RATS

      Antimicrobial agents and chemotherapy
    96. ALABDELY HM; GRAYBILL JR; BOCANEGRA R; NAJVAR L; MONTALBO E; REGEN SL; MELBY PC
      EFFICACIES OF KY62 AGAINST LEISHMANIA-AMAZONENSIS AND LEISHMANIA-DONOVANI IN EXPERIMENTAL MURINE CUTANEOUS LEISHMANIASIS AND VISCERAL LEISHMANIASIS

      Antimicrobial agents and chemotherapy
    97. OTSUBO T; MARUYAMA K; MAESAKI S; MIYAZAKI Y; TANAKA E; TAKIZAWA T; MORIBE K; TOMONO K; TASHIRO T; KOHNO S
      LONG-CIRCULATING IMMUNOLIPOSOMAL AMPHOTERICIN-B AGAINST INVASIVE PULMONARY ASPERGILLOSIS IN MICE

      Antimicrobial agents and chemotherapy
    98. MIGUELEZ M; LUMBRERAS C; HERRERO JA; AGUADO JM; DELPALACIO A; COLINA F; GOMEZ R; LIZASOAIN M; MORENO E; RODRIGUEZNORIEGA A
      INVASIVE FUNGAL-INFECTIONS IN LIVER-TRANS PLANT RECIPIENTS - ANALYSISOF 21 CASES

      Medicina Clinica
    99. COUKELL AJ; BROGDEN RN
      LIPOSOMAL AMPHOTERICIN-B - THERAPEUTIC USE IN THE MANAGEMENT OF FUNGAL-INFECTIONS AND VISCERAL LEISHMANIASIS

      Drugs
    100. CLARK AD; MCKENDRICK S; TANSEY PJ; FRANKLIN IM; CHOPRA R
      A COMPARATIVE-ANALYSIS OF LIPID-COMPLEXED AND LIPOSOMAL AMPHOTERICIN-B PREPARATIONS IN HEMATOLOGICAL ONCOLOGY

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 00:47:32